Privacy Policy
Terms of Use
Disclaimer
Sitemap
Home
About
Management Team
Overview
Board of Directors
Advisory Board
Markets
About Cell Therapy
Regnerative Medicine
Immuno-Oncology
Diabetes
Manufacturing Service
MaSTherCell
Global Facilities/Afilliates
Proprietary Therapies
Transdifferentiation
Indications
The Process
Publications
Patents
News & Media
Overview
Press Releases
Events
Presentations
Video
Investors
Overview
News / Events
Company Information
Stock Data
SEC Filings
Corporate Governance
Contact
Privacy Policy
Terms of Use
Disclaimer
Sitemap
News & Media
News & Media
News & Media
Overview
Press Releases
Events
Presentations
Video
Latest News
Feb 14, 2019
Orgenesis Reports 85% Increase in Revenue and 139% Increase in Gross Profit for Fiscal 2018
Recent News
Feb 11, 2019
Orgenesis CEO to Participate in Panel at the 2019 BIO CEO & Investor Conference
Feb 6, 2019
Orgenesis’ CSO Sara Ferber to Present to the International Research Training Group Hosted by Technische Universität Dresden and the King's College London
Feb 5, 2019
Orgenesis Announces the Opening of New Offices and Laboratories at Accessia Pharma in Liège, Belgium to Support its Point of Care Cellular Therapy Platform
Jan 25, 2019
Orgenesis Announces U.S. Expansion of Masthercell Global Subsidiary
View All Press Releases
Latest Event
Feb 12, 2019 • 9:00am EST
2019 BIO CEO & Investor Conference
View All Events